Shaowei Bing

Zhejiang Province Key Laboratory Of Anti Cancer Drug Research
Hangzhou, 310058, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Chromosomal rearrangement-enhanced mRNA stability drives the oncogenic potential of fusion genes in pediatric leukemia.

Chromosomal rearrangement-enhanced mRNA stability drives the oncogenic potential of fusion genes in pediatric leukemia.

Journal: Haematologica

Published: May 19, 2025

Acyltransferase ZDHHC22 promotes N-Myc transcriptional activation to drive neuroblastoma progression and chemoresistance.

Acyltransferase ZDHHC22 promotes N-Myc transcriptional activation to drive neuroblastoma progression and chemoresistance.

Journal: Molecular cell

Published: October 14, 2024

Succinate dehydrogenase deficiency-driven succinate accumulation induces drug resistance in acute myeloid leukemia via ubiquitin-cullin regulation.

Succinate dehydrogenase deficiency-driven succinate accumulation induces drug resistance in acute myeloid leukemia via ubiquitin-cullin regulation.

Journal: Nature communications

Published: November 07, 2023

Disruption of the KLHL37-N-Myc complex restores N-Myc degradation and arrests neuroblastoma growth in mouse models.

Disruption of the KLHL37-N-Myc complex restores N-Myc degradation and arrests neuroblastoma growth in mouse models.

Journal: The Journal of clinical investigation

Published: October 17, 2023

Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment.

Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment.

Journal: Journal of medicinal chemistry

Published: September 26, 2023

A novel gene fusion RUNX1/ZNF423 promotes leukemic relapse of NUP98-rearranged AML.

A novel gene fusion RUNX1/ZNF423 promotes leukemic relapse of NUP98-rearranged AML.

Journal: Leukemia

Published: April 27, 2023

AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells.

AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells.

Journal: Acta pharmaceutica Sinica. B

Published: September 06, 2022

Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells.

Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells.

Journal: Acta pharmaceutica Sinica. B

Published: July 20, 2021

Targeting Cul3-scaffold E3 ligase complex via KLHL substrate adaptors for cancer therapy.

Targeting Cul3-scaffold E3 ligase complex via KLHL substrate adaptors for cancer therapy.

Journal: Pharmacological research

Published: February 28, 2021

Decreased microRNA-206 and its function in cervical cancer.

Decreased microRNA-206 and its function in cervical cancer.

Journal: European journal of gynaecological oncology

Published: January 19, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026